Related Experiment Video

Updated: Feb 16, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.7K

Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis

Xiaole Zhu1,2, Chenyuan Shi1,2, Yunpeng Peng1,2

  • 1Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.

Cell Proliferation
|December 22, 2017
PubMed
Abstract

Insights

Thymidine kinase 1 (TK1) is elevated in pancreatic cancer, driving tumor growth and progression. Inhibiting TK1 suppressed proliferation, indicating its potential as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Thymidine kinase 1 (TK1) is a DNA synthesis enzyme implicated in various cancers.
  • The role of TK1 in pancreatic ductal adenocarcinoma (PDAC) remains largely uncharacterized.
  • Understanding TK1's function is crucial for developing novel therapeutic strategies for PDAC.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of TK1 in pancreatic ductal adenocarcinoma (PDAC).
  • To determine the association between TK1 expression and clinicopathological features in PDAC patients.
  • To evaluate TK1 as a potential therapeutic target for PDAC.

Main Methods:

  • Immunohistochemistry, real-time PCR, and Western blot were used to analyze TK1 expression levels.
  • TK1 expression was correlated with clinicopathological characteristics of PDAC patients.
  • TK1 function was assessed using siRNA-mediated knockdown in PDAC cell lines and in vivo animal models.

Main Results:

  • TK1 expression was significantly higher in PDAC tissues compared to adjacent non-cancerous tissues.
  • Elevated TK1 levels correlated with PDAC progression and poorer patient prognosis.
  • TK1 knockdown inhibited cell proliferation by inducing S-phase arrest, mediated by P21 upregulation.
  • The transcription factor E2F-1 was identified as a direct regulator of TK1, promoting tumor proliferation.

Conclusions:

  • TK1 plays a significant role in the development and progression of PDAC by regulating cell proliferation.
  • TK1 acts as an oncogene in PDAC, driven by E2F-1.
  • TK1 represents a promising therapeutic target for patients diagnosed with pancreatic ductal adenocarcinoma.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.8K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K